The Uromigos
Advertisement
Professor Shankar Siva joins the show to discuss the emerging role of stereotactic body radiotherapy in RCC tumors.
Dr. Dorff reviews expectations for GU oncology updates in 2025.
Dr. Silke Gillessen is joined by special guests to discuss the top highlights from 2024 in the prostate cancer field.
Dr. Matt Galsky joins Brian and Tom to discuss the most impactful data in bladder cancer from 2024.
Dr. David McDermott joins the podcast to review the top data from 2024 in the renal cell carcinoma field.
Dr. Jim Brugarolas joins the podcast to discuss his talk from IKCS 2024 and the broad topic of resistance to HIF inhibitors.
Dan Suzman, Deputy Oncology Director of the FDA, joins the podcast to discuss the Accelerated Approval process.
Jonathan Rosenberg joins the podcast to discuss new updates on the phase 3 TROPiCS-04 study.
Jakob Kather speaks with Brian and Tom on the use of artificial intelligence in the oncology landscape.
Dr. Bishoy Faltas of Weill Cornell Medicine joins us to discuss his work on extrachromosomal DNA in bladder cancer.
Dr. Andrew Smith, chair of diagnostic imaging at St. Jude's, joins the podcast to discuss the emerging field of radiomics.
Chuck Ryan, MD, joins the podcast to discuss various aspects of AR inhibition in prostate cancer.
Brian and Tom are joined by Dr. Chris Sweeney and Rob Jones to discuss the merits of various ARPIs in prostate cancer.
Returning guests Bertrand Tombal and Silke Gillessen join the podcast to dive into data from the 2024 APCCC.
Special guest Bertrand Tombal of Manchester Cancer Research Centre focuses on the historic and current data of AR inhibition
Christopher Cutie from J and J joins the show to discuss the SUNRISE bladder program.
Listen to the podcast format of the kidney cancer panel on IO after IO therapy from Uromigos Live 2024.
Drs. Maite Bourlon, Elena Castro and Cristina Suarez cover the UC topics discussed on day 1 of Uromigos Live 2024.
Listen to the podcast format of the peri-operative therapy in bladder cancer panel from Uromigos Live 2024.
Listen to the podcast format of the kidney cancer panel on TKI vs Ipi/Nivo vs IO/TKI from Uromigos Live 2024.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.